Impact of AI on Trainee ADR

Launched by UNIVERSITY OF SOUTHERN CALIFORNIA · Jun 14, 2022

Keywords

ClinConnect Summary

This clinical trial is studying how artificial intelligence (AI) can help improve the ability of Gastroenterology trainees to detect adenomas, which are growths that can lead to colorectal cancer if not found early. The researchers want to see if using AI technology during colonoscopy procedures can increase the adenoma detection rate (ADR), which is an important measure of how well doctors are identifying these growths. This study will involve Gastroenterology fellows at USC who are learning to perform endoscopies, and it will be carried out in a fair and organized way by dividing participants into groups.

To be eligible for this trial, participants must be Gastroenterology fellows at USC who are actively performing endoscopies. It’s important to note that if a fellow chooses not to give their consent to participate, they will not be included in the study. The AI system will only be used in the endoscopy unit and not in other medical settings like the intensive care unit or operating room. By participating, trainees can expect to use advanced technology that may help improve their skills in detecting adenomas, ultimately leading to better outcomes for patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All Gastroenterology fellows at USC performing Endoscopies will be included in the study.
• Exclusion Criteria:
• • If fellows refuse informed consent they will be excluded.
• • Procedures performed in the intensive care unit or the operating room will not be counted toward the study metrics as the AI system will only be available in the endoscopy unit.
• • If procedures are performed only by faculty, in which the fellow is not the primary operator, they will not be used for study metrics.